The reiteration of a Buy rating and a maintained price target of $95 by a reputable analyst like Joseph Stringer from Needham is likely to instill confidence among investors and could positively impact Vaxcyte's stock price in the short term. Analyst ratings, especially from well-regarded financial institutions, can significantly influence investor sentiment and stock prices.